This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of bioactive molecules. It serves as a key intermediate in the creation of compounds targeting central nervous system disorders, such as anxiety and depression, due to its structural properties that allow for modulation of neurotransmitter activity. Additionally, it is employed in the development of potential therapeutic agents for inflammatory and cardiovascular diseases, leveraging its trifluoromethyl group to enhance metabolic stability and bioavailability. Its application extends to agrochemical research, where it is explored for the design of novel pesticides and herbicides, benefiting from its ability to interact with specific biological pathways in pests and weeds.